Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Oxaliplatin 24 Fluorouracil 20 Capecitabine 16 pembrolizumab 15 Nivolumab 15 Leucovorin 13 Trastuzumab 9 fludarabine 8 Paclitaxel 8 Drug Therapy 8 Docetaxel 8 Cyclophosphamide 8 S 1 (combination) 7 trastuzumab deruxtecan 6 Specimen Handling 6 Cisplatin 6 Magnetic Resonance Spectroscopy 5 Bevacizumab 5 zolbetuximab 4 Irinotecan 4 Biopsy 4 zimberelimab 3 sintilimab 3 fludarabine phosphate 3 atezolizumab 3 aldesleukin 3 XELOX 3 Surgical Procedures, Operative 3 Ramucirumab 3 Radiotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × bemarituzumab × 90 days × Clear all

NCT05052801 2026-05-27

FORTITUDE-101

Amgen

Phase 3 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡